Showing results (521-530 of 533) with videos related to
Sort By:
Pageof 54
Ophthalmology|February 13, 2018
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL IIIEric B Suhler, Alfredo Adán, Antoine P Brézin, et al.Biorxiv : the Preprint Server for Biology|October 9, 2023
Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal DegenerationJian Liu, David A Copland, Alison J Clare, et al.Scientific Reports|April 3, 2026
Tissue resident memory T cells populate the human uveal tractAndrew D Foers, Ian R Reekie, Lakshanie C Wickramasinghe, et al.Journal of Medical Genetics|September 10, 2016
New insights into the genetic component of non-infectious uveitis through an Immunochip strategyAna Márquez, Miguel Cordero-Coma, José Manuel Martín-Villa, et al.Science Translational Medicine|June 5, 2024
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degenerationJian Liu, David A Copland, Alison J Clare, et al.Ophthalmology|November 6, 2020
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.Eye (London, England)|July 7, 2023
The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 2-global current practice patterns for the management of Cytomegalovirus anterior uveitisZheng Xian Thng, Ikhwanuliman Putera, Ilaria Testi, et al.American Journal of Ophthalmology|September 10, 2017
Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case SeriesInge L Sarens, Ingele Casteels, Jordi Anton, et al.Eye (London, England)|July 7, 2023
The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1-global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitisZheng Xian Thng, Ikhwanuliman Putera, Ilaria Testi, et al.The Lancet. Diabetes & Endocrinology|February 4, 2018
Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trialRathie Rajendram, Peter N Taylor, Victoria J Wilson, et al.Pageof 54